| pubmed-article:15632666 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15632666 | lifeskim:mentions | umls-concept:C1801960 | lld:lifeskim |
| pubmed-article:15632666 | lifeskim:mentions | umls-concept:C0033306 | lld:lifeskim |
| pubmed-article:15632666 | lifeskim:mentions | umls-concept:C0221912 | lld:lifeskim |
| pubmed-article:15632666 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:15632666 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:15632666 | lifeskim:mentions | umls-concept:C0018851 | lld:lifeskim |
| pubmed-article:15632666 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:15632666 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:15632666 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15632666 | pubmed:dateCreated | 2005-1-5 | lld:pubmed |
| pubmed-article:15632666 | pubmed:abstractText | Oral contraceptives influence the regulation of cutaneous vascular tone, and both estrogen and progesterone have been shown to affect nitric oxide (NO)-mediated vasodilation. We tested the hypothesis that cutaneous vascular conductance (CVC) during passive heating would be lower in women taking oral contraceptives with higher progestational bioactivity compared with those taking oral contraceptives with lower progestational bioactivity. We further hypothesized that this difference could be attributed to the relative degree of NO-dependent vasodilation. | lld:pubmed |
| pubmed-article:15632666 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15632666 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15632666 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15632666 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15632666 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15632666 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15632666 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15632666 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15632666 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15632666 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:15632666 | pubmed:issn | 0195-9131 | lld:pubmed |
| pubmed-article:15632666 | pubmed:author | pubmed-author:MinsonChristo... | lld:pubmed |
| pubmed-article:15632666 | pubmed:author | pubmed-author:HolowatzLacy... | lld:pubmed |
| pubmed-article:15632666 | pubmed:author | pubmed-author:HoughtonBelin... | lld:pubmed |
| pubmed-article:15632666 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15632666 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:15632666 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15632666 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15632666 | pubmed:pagination | 45-51; discussion 52 | lld:pubmed |
| pubmed-article:15632666 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:15632666 | pubmed:meshHeading | pubmed-meshheading:15632666... | lld:pubmed |
| pubmed-article:15632666 | pubmed:meshHeading | pubmed-meshheading:15632666... | lld:pubmed |
| pubmed-article:15632666 | pubmed:meshHeading | pubmed-meshheading:15632666... | lld:pubmed |
| pubmed-article:15632666 | pubmed:meshHeading | pubmed-meshheading:15632666... | lld:pubmed |
| pubmed-article:15632666 | pubmed:meshHeading | pubmed-meshheading:15632666... | lld:pubmed |
| pubmed-article:15632666 | pubmed:meshHeading | pubmed-meshheading:15632666... | lld:pubmed |
| pubmed-article:15632666 | pubmed:meshHeading | pubmed-meshheading:15632666... | lld:pubmed |
| pubmed-article:15632666 | pubmed:meshHeading | pubmed-meshheading:15632666... | lld:pubmed |
| pubmed-article:15632666 | pubmed:meshHeading | pubmed-meshheading:15632666... | lld:pubmed |
| pubmed-article:15632666 | pubmed:meshHeading | pubmed-meshheading:15632666... | lld:pubmed |
| pubmed-article:15632666 | pubmed:meshHeading | pubmed-meshheading:15632666... | lld:pubmed |
| pubmed-article:15632666 | pubmed:meshHeading | pubmed-meshheading:15632666... | lld:pubmed |
| pubmed-article:15632666 | pubmed:meshHeading | pubmed-meshheading:15632666... | lld:pubmed |
| pubmed-article:15632666 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15632666 | pubmed:articleTitle | Influence of progestin bioactivity on cutaneous vascular responses to passive heating. | lld:pubmed |
| pubmed-article:15632666 | pubmed:affiliation | Department of Human Physiology, University of Oregon, Eugene, OR, USA. | lld:pubmed |
| pubmed-article:15632666 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15632666 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15632666 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:15632666 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:15632666 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15632666 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
